NR4A1 and breast cancer: Our subsequent analysis of WAVE3 expression in the blood of 200 BC patients proved that WAVE3 expression levels correlate positively with adverse disease characteristics, namely, tumor nuclear grade, SBR grade and hormone receptors status.